Cargando…
Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study
INTRODUCTION: We estimated the cost effectiveness of concomitant proton pump inhibitors (PPIs) in relation to the occurrence of non-steroidal anti-inflammatory drug (NSAID) ulcer complications. METHODS: This study was linked to a nested case-control study. Patients with NSAID ulcer complications wer...
Autores principales: | Vonkeman, Harald E, Braakman-Jansen, Louise MA, Klok, Rogier M, Postma, Maarten J, Brouwers, Jacobus RBJ, van de Laar, Mart AFJ |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656249/ https://www.ncbi.nlm.nih.gov/pubmed/19077318 http://dx.doi.org/10.1186/ar2577 |
Ejemplares similares
-
Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study
por: Vonkeman, Harald E, et al.
Publicado: (2007) -
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
por: Meek, Inger L., et al.
Publicado: (2010) -
Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin
por: Vonkeman, Harald, et al.
Publicado: (2010) -
Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature
por: Meek, Inger L, et al.
Publicado: (2014) -
Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort
por: Meek, Inger L, et al.
Publicado: (2014)